SlideShare a Scribd company logo
1 of 14
SEVERITY AND SERIOUSNESS
ASSESSMENT OF ADR
Dr. Ramesh Bhandari
Asst. Professor
Department of Pharmacy Practice,
KLE College of Pharmacy, Belagavi
SEVERITY
•The term severity is often used to describe the
intensity of a medical event.
•Severity assessment categorizes the ADRs as
mild, moderate or severe based on the steps taken
for the management of the ADRs.
SEVERITY
• KARCH AND LASAGNA classified severity into minor, moderate,
severe and lethal as defined below:
 Minor: No antidote, treatment or prolongation of hospitalization
required.
 Moderate: A change in drug therapy (e.g.: modified dosage, addition
of a drug), but not necessarily discontinuation of the drug is required;
hospitalization may be prolonged, or specific treatment may be
required.
 Severe: Potentially life threatening, causing permanent damage or
requiring intensive medical care. Requires drug discontinuation.
 Lethal: Directly or indirectly contributes to the death of the patient.
MODIFIED HARTWIG’S AND SIEGELASSESSMENT SCALE
• Hartwig et. al robustly categorized ADR severity into seven
levels according to clinical consequence, including resultant
harm and intensity of medical intervention required.
oLevel 1 and 2 fall under mild category
oLevel 3 and 4 fall under moderate category
oLevel 5, 6 and 7 fall under category severe category.
Modified Hartwig and Siegel
• Mild:
Level 1: The ADR requires no change in treatment with the
suspected drug
Level 2: The ADR requires that the suspected drug be withheld,
discontinued or otherwise changed. NO antidote or other
treatment is required, and there is no increase in length of stay.
Modified Hartwig and Siegel
• Moderate:
Level 3: The ADR requires that the suspected drug be withheld,
discontinued or otherwise changed, and / or an antidote or
other treatment is required. There is no increase in length of
stay
Level 4 (a): Any level 3 ADR that increases length of stay by at
least one day
Level 4 (b): The ADR is the reason for admission.
Modified Hartwig and Siegel
• Severe:
Level 5: Any level 4 ADR that requires intensive medical care.
Level 6: The ADR causes permanent harm to the patient
Level 7: The ADR either directly or indirectly leads to the death
of the patient.
SERIOUSNESS CLASSIFICATION
• A serious adverse event or reaction is any untoward medical
occurrence that at any dose:
 Results in death
 Is life threatening
 Requires inpatient hospitalization or prolong hospitalization
 Results in persistent or significant disability
 Is a congenital anomaly/birth defect
PREVENTABILITY AND
PREDICTABILITY OF ADRs
PREVENTABILITY OFADRs
• Schumock and Thornton criteria:
• It has three sections namely definitely preventable, probably preventable and not-preventable.
• Section A comprises of five questions while section B has four questions.
• All the answers are categorized as “yes” or “no”.
• ADRs are “definitely preventable” if answer was “yes” to one or more questions in section A.
• If answers are all negative (“no”), then proceed to section B
• ADRs are “probably preventable” if answer was “yes” to one or more questions in section B.
• If answers were all negative then proceed to section C.
• In section C, the ADRs are not-preventable.
PREDICTABILITY Of ADRs
• Type A (Predictable):
Extension of pharmacological effect
Often predictable and dose dependent
Example: Dry mouth induced by anti-cholinergics.
• Type B (Non-predictable):
Idiosyncratic or immunologic reactions
Rare and unpredictable
Example: Penicillin induced anaphylactic shock.
REFERENCES
1. Karch FE, Lasagna L. Adverse drug reactions. JAMA. 1975;
234(12):1236
2. S. K. Gupta. Textbook of Pharmacovigilance. 2nd Edition. Jaypee
Brothers Medical Publishers. 2019.
THANK YOU

More Related Content

What's hot

Detection and monitoring of ADRs
Detection and monitoring of ADRsDetection and monitoring of ADRs
Detection and monitoring of ADRsDr. Ramesh Bhandari
 
History and progress of pharmacovigilance
History and progress of pharmacovigilanceHistory and progress of pharmacovigilance
History and progress of pharmacovigilanceGagandeep Jaiswal
 
Pharmacovigilance programme of india
Pharmacovigilance programme of indiaPharmacovigilance programme of india
Pharmacovigilance programme of indiachandan kumar
 
Establishing Pharmacovigilance Centres In Hospital.pptx
Establishing Pharmacovigilance Centres In Hospital.pptxEstablishing Pharmacovigilance Centres In Hospital.pptx
Establishing Pharmacovigilance Centres In Hospital.pptxRushikeshTidake
 
Regulatory terminologies used in PV (Pharmacovigilance)
Regulatory terminologies used in PV (Pharmacovigilance)Regulatory terminologies used in PV (Pharmacovigilance)
Regulatory terminologies used in PV (Pharmacovigilance)MubasheeraMg
 
Establishment of Pharmacovigilance Programme
Establishment of Pharmacovigilance ProgrammeEstablishment of Pharmacovigilance Programme
Establishment of Pharmacovigilance ProgrammeNipun Gupta
 
1.2 Importance of safety monitoring of Medicine.pptx
1.2 Importance of safety monitoring of Medicine.pptx1.2 Importance of safety monitoring of Medicine.pptx
1.2 Importance of safety monitoring of Medicine.pptxReshmaManeDeshmukh
 
Vaccine safety surveillance
Vaccine safety surveillanceVaccine safety surveillance
Vaccine safety surveillanceDr Priyanka Goswami
 
Causality Assessment ADR.pdf
Causality Assessment ADR.pdfCausality Assessment ADR.pdf
Causality Assessment ADR.pdfDr. Ramesh Bhandari
 
Standardized and MedDRA Queries
Standardized and MedDRA QueriesStandardized and MedDRA Queries
Standardized and MedDRA QueriesRajat Garg
 
History n progress of pv
History n progress of pvHistory n progress of pv
History n progress of pvRamavath Aruna
 
Pharmacovigilance & Adverse drug reaction
Pharmacovigilance & Adverse drug reactionPharmacovigilance & Adverse drug reaction
Pharmacovigilance & Adverse drug reactionRahul Bhati
 
International nonproprietary names
International nonproprietary namesInternational nonproprietary names
International nonproprietary namesAltacit Global
 
CIOMS (1).pptx
CIOMS (1).pptxCIOMS (1).pptx
CIOMS (1).pptxSanjay522244
 
Adverse drug reaction monitoring and reporting
Adverse drug reaction monitoring and reportingAdverse drug reaction monitoring and reporting
Adverse drug reaction monitoring and reportingTHUSHARA MOHAN
 

What's hot (20)

Schedule y
Schedule ySchedule y
Schedule y
 
Detection and monitoring of ADRs
Detection and monitoring of ADRsDetection and monitoring of ADRs
Detection and monitoring of ADRs
 
History and progress of pharmacovigilance
History and progress of pharmacovigilanceHistory and progress of pharmacovigilance
History and progress of pharmacovigilance
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
Pharmacovigilance programme of india
Pharmacovigilance programme of indiaPharmacovigilance programme of india
Pharmacovigilance programme of india
 
Establishing Pharmacovigilance Centres In Hospital.pptx
Establishing Pharmacovigilance Centres In Hospital.pptxEstablishing Pharmacovigilance Centres In Hospital.pptx
Establishing Pharmacovigilance Centres In Hospital.pptx
 
Regulatory terminologies used in PV (Pharmacovigilance)
Regulatory terminologies used in PV (Pharmacovigilance)Regulatory terminologies used in PV (Pharmacovigilance)
Regulatory terminologies used in PV (Pharmacovigilance)
 
Establishment of Pharmacovigilance Programme
Establishment of Pharmacovigilance ProgrammeEstablishment of Pharmacovigilance Programme
Establishment of Pharmacovigilance Programme
 
CONTRACT RESEARCH ORGANIZATION
CONTRACT RESEARCH ORGANIZATIONCONTRACT RESEARCH ORGANIZATION
CONTRACT RESEARCH ORGANIZATION
 
1.2 Importance of safety monitoring of Medicine.pptx
1.2 Importance of safety monitoring of Medicine.pptx1.2 Importance of safety monitoring of Medicine.pptx
1.2 Importance of safety monitoring of Medicine.pptx
 
Vaccine safety surveillance
Vaccine safety surveillanceVaccine safety surveillance
Vaccine safety surveillance
 
Causality Assessment ADR.pdf
Causality Assessment ADR.pdfCausality Assessment ADR.pdf
Causality Assessment ADR.pdf
 
Standardized and MedDRA Queries
Standardized and MedDRA QueriesStandardized and MedDRA Queries
Standardized and MedDRA Queries
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
History n progress of pv
History n progress of pvHistory n progress of pv
History n progress of pv
 
Pharmacovigilance & Adverse drug reaction
Pharmacovigilance & Adverse drug reactionPharmacovigilance & Adverse drug reaction
Pharmacovigilance & Adverse drug reaction
 
Pharmacovigilance program of India
Pharmacovigilance program of IndiaPharmacovigilance program of India
Pharmacovigilance program of India
 
International nonproprietary names
International nonproprietary namesInternational nonproprietary names
International nonproprietary names
 
CIOMS (1).pptx
CIOMS (1).pptxCIOMS (1).pptx
CIOMS (1).pptx
 
Adverse drug reaction monitoring and reporting
Adverse drug reaction monitoring and reportingAdverse drug reaction monitoring and reporting
Adverse drug reaction monitoring and reporting
 

Similar to Severity, seriousness, predictability and preventability assessment

Collection, Processing and Reporting of ICSR
Collection, Processing and Reporting of ICSRCollection, Processing and Reporting of ICSR
Collection, Processing and Reporting of ICSRClinosolIndia
 
Adverse Drug Reactions.pptx
Adverse Drug Reactions.pptxAdverse Drug Reactions.pptx
Adverse Drug Reactions.pptxAjithJs2
 
The Prospective Study Of Adverse Drug Reactions in Surgical Wards of a Tertia...
The Prospective Study Of Adverse Drug Reactions in Surgical Wards of a Tertia...The Prospective Study Of Adverse Drug Reactions in Surgical Wards of a Tertia...
The Prospective Study Of Adverse Drug Reactions in Surgical Wards of a Tertia...dr venu d
 
Changing Anti-Retroviral Therapy
Changing Anti-Retroviral TherapyChanging Anti-Retroviral Therapy
Changing Anti-Retroviral Therapyshabeel pn
 
03.02 management of patients on antiretroviral drugs initiat
03.02 management of patients on antiretroviral drugs initiat03.02 management of patients on antiretroviral drugs initiat
03.02 management of patients on antiretroviral drugs initiatDavid Ngogoyo
 
02.02 adult art initiation gsn
02.02 adult  art initiation gsn02.02 adult  art initiation gsn
02.02 adult art initiation gsnDavid Ngogoyo
 
Adverse-Drug-Reactions-Patient-Level-by-Prof-Jamie-Coleman.pptx
Adverse-Drug-Reactions-Patient-Level-by-Prof-Jamie-Coleman.pptxAdverse-Drug-Reactions-Patient-Level-by-Prof-Jamie-Coleman.pptx
Adverse-Drug-Reactions-Patient-Level-by-Prof-Jamie-Coleman.pptxDeepali69
 
Adverse drug reaction for BPH
Adverse drug reaction for BPHAdverse drug reaction for BPH
Adverse drug reaction for BPHPravin Prasad
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactionssantoshi sahu
 
Causality assessment scales
Causality assessment scalesCausality assessment scales
Causality assessment scalesDr Renju Ravi
 
ADR and pharmacovigillance
ADR and pharmacovigillanceADR and pharmacovigillance
ADR and pharmacovigillanceNesNalNiraula1
 
adverse drug rxn.ppt
adverse drug rxn.pptadverse drug rxn.ppt
adverse drug rxn.pptSeema Bansal
 
Adverse Drug Reactions - Identifying, Causality & Reporting
Adverse Drug Reactions - Identifying, Causality & ReportingAdverse Drug Reactions - Identifying, Causality & Reporting
Adverse Drug Reactions - Identifying, Causality & ReportingRuella D'Costa Fernandes
 
ADRppt.pptx
ADRppt.pptxADRppt.pptx
ADRppt.pptxNiyasp8
 

Similar to Severity, seriousness, predictability and preventability assessment (20)

ADVERSE DRUG REACTION
ADVERSE DRUG  REACTIONADVERSE DRUG  REACTION
ADVERSE DRUG REACTION
 
Collection, Processing and Reporting of ICSR
Collection, Processing and Reporting of ICSRCollection, Processing and Reporting of ICSR
Collection, Processing and Reporting of ICSR
 
Adverse Drug Reactions.pptx
Adverse Drug Reactions.pptxAdverse Drug Reactions.pptx
Adverse Drug Reactions.pptx
 
The Prospective Study Of Adverse Drug Reactions in Surgical Wards of a Tertia...
The Prospective Study Of Adverse Drug Reactions in Surgical Wards of a Tertia...The Prospective Study Of Adverse Drug Reactions in Surgical Wards of a Tertia...
The Prospective Study Of Adverse Drug Reactions in Surgical Wards of a Tertia...
 
Changing Anti-Retroviral Therapy
Changing Anti-Retroviral TherapyChanging Anti-Retroviral Therapy
Changing Anti-Retroviral Therapy
 
03.02 management of patients on antiretroviral drugs initiat
03.02 management of patients on antiretroviral drugs initiat03.02 management of patients on antiretroviral drugs initiat
03.02 management of patients on antiretroviral drugs initiat
 
02.02 adult art initiation gsn
02.02 adult  art initiation gsn02.02 adult  art initiation gsn
02.02 adult art initiation gsn
 
Adverse Drug Reactions
Adverse Drug ReactionsAdverse Drug Reactions
Adverse Drug Reactions
 
Adverse-Drug-Reactions-Patient-Level-by-Prof-Jamie-Coleman.pptx
Adverse-Drug-Reactions-Patient-Level-by-Prof-Jamie-Coleman.pptxAdverse-Drug-Reactions-Patient-Level-by-Prof-Jamie-Coleman.pptx
Adverse-Drug-Reactions-Patient-Level-by-Prof-Jamie-Coleman.pptx
 
Handout adr
Handout adrHandout adr
Handout adr
 
Adverse drug reaction for BPH
Adverse drug reaction for BPHAdverse drug reaction for BPH
Adverse drug reaction for BPH
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
Causality assessment scales
Causality assessment scalesCausality assessment scales
Causality assessment scales
 
ADR and pharmacovigillance
ADR and pharmacovigillanceADR and pharmacovigillance
ADR and pharmacovigillance
 
adverse drug rxn.ppt
adverse drug rxn.pptadverse drug rxn.ppt
adverse drug rxn.ppt
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Adverse Drug Reactions - Identifying, Causality & Reporting
Adverse Drug Reactions - Identifying, Causality & ReportingAdverse Drug Reactions - Identifying, Causality & Reporting
Adverse Drug Reactions - Identifying, Causality & Reporting
 
pharmaceutical care
pharmaceutical carepharmaceutical care
pharmaceutical care
 
ADRppt.pptx
ADRppt.pptxADRppt.pptx
ADRppt.pptx
 

More from Dr. Ramesh Bhandari

Microbiological culture sensitivity tests
Microbiological culture sensitivity testsMicrobiological culture sensitivity tests
Microbiological culture sensitivity testsDr. Ramesh Bhandari
 
Respiratory and Intestinal infections
Respiratory and Intestinal infectionsRespiratory and Intestinal infections
Respiratory and Intestinal infectionsDr. Ramesh Bhandari
 
Effect of environment on health
Effect of environment on healthEffect of environment on health
Effect of environment on healthDr. Ramesh Bhandari
 
Demography, demographic cycle and family planning methods
Demography, demographic cycle and family planning methodsDemography, demographic cycle and family planning methods
Demography, demographic cycle and family planning methodsDr. Ramesh Bhandari
 
National health policy, MDGs, SDPs, and FIP Development Goals
National health policy, MDGs, SDPs, and FIP Development GoalsNational health policy, MDGs, SDPs, and FIP Development Goals
National health policy, MDGs, SDPs, and FIP Development GoalsDr. Ramesh Bhandari
 
Concept, Dimension, Determinants, and Indicators of health
Concept, Dimension, Determinants, and Indicators of healthConcept, Dimension, Determinants, and Indicators of health
Concept, Dimension, Determinants, and Indicators of healthDr. Ramesh Bhandari
 
Social pharmacy, National Health Mission
Social pharmacy, National Health MissionSocial pharmacy, National Health Mission
Social pharmacy, National Health MissionDr. Ramesh Bhandari
 
ICH Guidelines for Pharmacovigilance
ICH Guidelines for PharmacovigilanceICH Guidelines for Pharmacovigilance
ICH Guidelines for PharmacovigilanceDr. Ramesh Bhandari
 
Reporting of pharmacovigilance and role of pharmacist
Reporting of pharmacovigilance and role of pharmacistReporting of pharmacovigilance and role of pharmacist
Reporting of pharmacovigilance and role of pharmacistDr. Ramesh Bhandari
 
Dose adjustment in Renal Disorders
Dose adjustment in Renal DisordersDose adjustment in Renal Disorders
Dose adjustment in Renal DisordersDr. Ramesh Bhandari
 
Population pharmacokinetics
Population pharmacokineticsPopulation pharmacokinetics
Population pharmacokineticsDr. Ramesh Bhandari
 

More from Dr. Ramesh Bhandari (20)

Designing Protocol.pdf
Designing Protocol.pdfDesigning Protocol.pdf
Designing Protocol.pdf
 
Communicable diseases
Communicable diseasesCommunicable diseases
Communicable diseases
 
Microbiological culture sensitivity tests
Microbiological culture sensitivity testsMicrobiological culture sensitivity tests
Microbiological culture sensitivity tests
 
Respiratory and Intestinal infections
Respiratory and Intestinal infectionsRespiratory and Intestinal infections
Respiratory and Intestinal infections
 
Epidemiology
EpidemiologyEpidemiology
Epidemiology
 
Microbiology
MicrobiologyMicrobiology
Microbiology
 
Nutrition and Food
Nutrition and FoodNutrition and Food
Nutrition and Food
 
Effect of environment on health
Effect of environment on healthEffect of environment on health
Effect of environment on health
 
Vaccine and immunity
Vaccine and immunityVaccine and immunity
Vaccine and immunity
 
Psychosocial pharmacy
Psychosocial pharmacyPsychosocial pharmacy
Psychosocial pharmacy
 
Nutrition
NutritionNutrition
Nutrition
 
Mother and child health
Mother and child healthMother and child health
Mother and child health
 
Demography, demographic cycle and family planning methods
Demography, demographic cycle and family planning methodsDemography, demographic cycle and family planning methods
Demography, demographic cycle and family planning methods
 
National health policy, MDGs, SDPs, and FIP Development Goals
National health policy, MDGs, SDPs, and FIP Development GoalsNational health policy, MDGs, SDPs, and FIP Development Goals
National health policy, MDGs, SDPs, and FIP Development Goals
 
Concept, Dimension, Determinants, and Indicators of health
Concept, Dimension, Determinants, and Indicators of healthConcept, Dimension, Determinants, and Indicators of health
Concept, Dimension, Determinants, and Indicators of health
 
Social pharmacy, National Health Mission
Social pharmacy, National Health MissionSocial pharmacy, National Health Mission
Social pharmacy, National Health Mission
 
ICH Guidelines for Pharmacovigilance
ICH Guidelines for PharmacovigilanceICH Guidelines for Pharmacovigilance
ICH Guidelines for Pharmacovigilance
 
Reporting of pharmacovigilance and role of pharmacist
Reporting of pharmacovigilance and role of pharmacistReporting of pharmacovigilance and role of pharmacist
Reporting of pharmacovigilance and role of pharmacist
 
Dose adjustment in Renal Disorders
Dose adjustment in Renal DisordersDose adjustment in Renal Disorders
Dose adjustment in Renal Disorders
 
Population pharmacokinetics
Population pharmacokineticsPopulation pharmacokinetics
Population pharmacokinetics
 

Recently uploaded

Biting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfBiting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfadityarao40181
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatYousafMalik24
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...M56BOOKSTORE PRODUCT/SERVICE
 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfUjwalaBharambe
 
MARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupMARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupJonathanParaisoCruz
 
ESSENTIAL of (CS/IT/IS) class 06 (database)
ESSENTIAL of (CS/IT/IS) class 06 (database)ESSENTIAL of (CS/IT/IS) class 06 (database)
ESSENTIAL of (CS/IT/IS) class 06 (database)Dr. Mazin Mohamed alkathiri
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxthorishapillay1
 
Types of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxTypes of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxEyham Joco
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxHistory Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxsocialsciencegdgrohi
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
18-04-UA_REPORT_MEDIALITERAĐĄY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAĐĄY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAĐĄY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAĐĄY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxiammrhaywood
 

Recently uploaded (20)

Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
Biting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfBiting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdf
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice great
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
 
MARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupMARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized Group
 
ESSENTIAL of (CS/IT/IS) class 06 (database)
ESSENTIAL of (CS/IT/IS) class 06 (database)ESSENTIAL of (CS/IT/IS) class 06 (database)
ESSENTIAL of (CS/IT/IS) class 06 (database)
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptx
 
Types of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxTypes of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptx
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxHistory Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
9953330565 Low Rate Call Girls In Rohini Delhi NCR
9953330565 Low Rate Call Girls In Rohini  Delhi NCR9953330565 Low Rate Call Girls In Rohini  Delhi NCR
9953330565 Low Rate Call Girls In Rohini Delhi NCR
 
18-04-UA_REPORT_MEDIALITERAĐĄY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAĐĄY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAĐĄY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAĐĄY_INDEX-DM_23-1-final-eng.pdf
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
 

Severity, seriousness, predictability and preventability assessment

  • 1. SEVERITY AND SERIOUSNESS ASSESSMENT OF ADR Dr. Ramesh Bhandari Asst. Professor Department of Pharmacy Practice, KLE College of Pharmacy, Belagavi
  • 2. SEVERITY •The term severity is often used to describe the intensity of a medical event. •Severity assessment categorizes the ADRs as mild, moderate or severe based on the steps taken for the management of the ADRs.
  • 3. SEVERITY • KARCH AND LASAGNA classified severity into minor, moderate, severe and lethal as defined below:  Minor: No antidote, treatment or prolongation of hospitalization required.  Moderate: A change in drug therapy (e.g.: modified dosage, addition of a drug), but not necessarily discontinuation of the drug is required; hospitalization may be prolonged, or specific treatment may be required.  Severe: Potentially life threatening, causing permanent damage or requiring intensive medical care. Requires drug discontinuation.  Lethal: Directly or indirectly contributes to the death of the patient.
  • 4. MODIFIED HARTWIG’S AND SIEGELASSESSMENT SCALE • Hartwig et. al robustly categorized ADR severity into seven levels according to clinical consequence, including resultant harm and intensity of medical intervention required. oLevel 1 and 2 fall under mild category oLevel 3 and 4 fall under moderate category oLevel 5, 6 and 7 fall under category severe category.
  • 5. Modified Hartwig and Siegel • Mild: Level 1: The ADR requires no change in treatment with the suspected drug Level 2: The ADR requires that the suspected drug be withheld, discontinued or otherwise changed. NO antidote or other treatment is required, and there is no increase in length of stay.
  • 6. Modified Hartwig and Siegel • Moderate: Level 3: The ADR requires that the suspected drug be withheld, discontinued or otherwise changed, and / or an antidote or other treatment is required. There is no increase in length of stay Level 4 (a): Any level 3 ADR that increases length of stay by at least one day Level 4 (b): The ADR is the reason for admission.
  • 7. Modified Hartwig and Siegel • Severe: Level 5: Any level 4 ADR that requires intensive medical care. Level 6: The ADR causes permanent harm to the patient Level 7: The ADR either directly or indirectly leads to the death of the patient.
  • 8. SERIOUSNESS CLASSIFICATION • A serious adverse event or reaction is any untoward medical occurrence that at any dose:  Results in death  Is life threatening  Requires inpatient hospitalization or prolong hospitalization  Results in persistent or significant disability  Is a congenital anomaly/birth defect
  • 10. PREVENTABILITY OFADRs • Schumock and Thornton criteria: • It has three sections namely definitely preventable, probably preventable and not-preventable. • Section A comprises of five questions while section B has four questions. • All the answers are categorized as “yes” or “no”. • ADRs are “definitely preventable” if answer was “yes” to one or more questions in section A. • If answers are all negative (“no”), then proceed to section B • ADRs are “probably preventable” if answer was “yes” to one or more questions in section B. • If answers were all negative then proceed to section C. • In section C, the ADRs are not-preventable.
  • 11.
  • 12. PREDICTABILITY Of ADRs • Type A (Predictable): Extension of pharmacological effect Often predictable and dose dependent Example: Dry mouth induced by anti-cholinergics. • Type B (Non-predictable): Idiosyncratic or immunologic reactions Rare and unpredictable Example: Penicillin induced anaphylactic shock.
  • 13. REFERENCES 1. Karch FE, Lasagna L. Adverse drug reactions. JAMA. 1975; 234(12):1236 2. S. K. Gupta. Textbook of Pharmacovigilance. 2nd Edition. Jaypee Brothers Medical Publishers. 2019.